Integrated Analysis of Quality Use of Pathology Program (qupp) Final Reports
Yüklə 0,88 Mb.
|
- Bu səhifədəki naviqasiya:
- Introduction
AbbreviationsAACB Australasian Association of Clinical Biochemists AAPP Australian Association of Pathology Practices AIHW Australian Institute of Health and Welfare APPN Australian Point of Care Practitioners Network ACRRM Australian College of Rural and Remote Medicine AMA Australian Medical Association BEACH Bettering the Evaluation and Care of Health CHF Consumers Health Forum of Australia DATIS Drug and Therapeutics Information Service DoHA Australian Government Department of Health and Ageing GP General Practitioner HGSA Human Genetics Society of Australasia HIC Health Insurance Commission HISA Health Informatics Society of Australia KPI Key Performance Indicators LTO Lab Tests Online MBS Medicare Benefits Schedule MTAAC Medical Testing Accreditation Advisory Committee NATA National Association of Testing Authorities NeHTA National E-Health Transition Authority NCOPP National Coalition of Public Pathology NHMRC National Health and Medical Research Council NPAAC National Pathology Accreditation Advisory Council NPS National Prescribing Service PAC Pathology Associations Council PFA Pathology Funding Agreement PoCT Point of Care Testing QHPSS Queensland Health Pathology & Scientific Services RACGP Royal Australian College of General Practitioners RACP Royal Australasian College of Physicians RACS Royal Australian College of Surgeons RCNA Royal College of Nursing Australia RCPA Royal College of Pathologists of Australasia RCPA QAP RCPA Quality Assurance Programs Pty Ltd QAAMS Quality Assurance for Aboriginal and Torres Strait Islander Medical Services QASEC Quality Assurance Scientific and Education Committee QUPC Quality Use of Pathology Committee QUPP Quality Use of Pathology Program WAC Workforce Advisory Committee
BackgroundThe Quality Use of Pathology Program (QUPP) was established in 1999 under the auspice of the 2nd pathology Memorandum of Understanding (MoU) with pathology stakeholders, and with up to $2 million notionally allocated per year for the funding of projects and other initiatives relating to improvements in the quality of pathology services. The program has been managed by the Australian Government Department of Health and Ageing (DoHA) in conjunction with the Quality Use of Pathology Committee (QUPC). The QUPC was originally a sub-committee of the Pathology Consultative Committee (PCC) formed to work with the Australian Government to manage pathology outlays under the MoU. But more recently it has been given a continued focus with the commencement of the five-year Pathology Funding Agreement (PFA) between the Commonwealth Government and key pathology stakeholders in April 2011. The QUPC provides advice relation to strategic directions and projects and/or initiatives implemented under the program. This committee currently comprises nominees from the pathology profession, general practice, the Royal Australasian College of Physicians, Doctors-in-Training, the Consumers Health Forum of Australia, Medical Deans Australia and New Zealand and representatives from the Department of Health and Ageing. Funding for the QUPP has been allocated by a combination of open funding rounds and targeted initiatives. The program has operated under overarching principles supported by guiding assumptions developed by DoHA and the QUPC in consultation with the broader pathology stakeholder sector. National workshops have been held each year since 2007 with the aim of bringing pathology, requester and consumer stakeholders together to discuss pathology quality and safety issues, to inform the QUPP priority setting process and debate the ways in which priority issues could be addressed. In 2005-2006 the QUPP was reviewed and the operation of the program was refined to address strategic issues outlined in the review report. Since the review, project funding has generally been targeted to three sub-programs with the following key objectives:
In recent years there has been an increasing focus on the funding of initiatives aimed at developing and testing strategies to minimise error and promote patient safety. This work is relevant to the strategic focus of the National Pathology Accreditation Advisory Council. Further information on the QUPP can be found on the Department of Health and Ageing website at http://www.health.gov.au/qupp. Terms of Reference for the project DoHA commissioned Cognitus Pty Ltd to conduct a comprehensive analysis of the Quality Use of Pathology Program project reports. The project objectives were:
The analysis was to cover the QUPP investment that has occurred over the past ten years which would record the investment to date made on the quality use of pathology. It is expected that this document would also provide a potential basis for any future evaluation of the program. Structure of the Report This document is structured according to nine themes based on the QUPP’s areas of focus:
There were 74 reports analysed for this integrated analysis, with each report assigned to one of the above themes. Each report was set out in the following template:
Many of the projects listed in this report fall into more than one theme – see Appendix A – Report Summaries Relevant to Different Themes. Yüklə 0,88 Mb. Dostları ilə paylaş:
|